For launches and development
that define medical impact
Lumares is the only Medical Affairs consultancy to have built global Medical Affairs launch readiness from a preclinical starting point in just six months, supporting one of the largest and most complex launches in biopharma history.
That achievement sits within a broader track record of leading and supporting multiple high-stakes global launches across novel and first-in-class platforms, and products seeking optimal scientific differentiation.
Crucially, we understand the landscape of corporate strategy, and our experience extends beyond execution but rather on corporate and medical impact in highly scientific fields.
Lumares has operated at the forefront of regulatory and health technology discussions for emerging platforms, sitting within major regulatory, payer, and health technology forums to help shape policy, guidance, and scientific frameworks for new technologies.
As active contributors and thought leaders in the scientific space, we understand not only what needs to be built in Medical Affairs but why it is needed, how expectations are formed, and how decisions will be assessed by regulators, health technology bodies, and external stakeholders over time.
This perspective enables us to design Medical Affairs strategies that are:
• grounded in future-facing regulatory and health technology expectations
• defensible under external stakeholder scrutiny
• aligned to scientific, medical and corporate impact
​
We design Medical Affairs with an understanding of how evidence, policy, and expectations are co-created, not discovered after the fact, keeping patients at the core.
What makes Lumares different
Lumares Strategy operates at the intersection of scientific innovation, Medical Affairs execution, and the regulatory and health technology environments that shape expectations for new platforms.
That experience sits within a broader track record of leading and supporting multiple high-stakes global launches, where policy, guidance, and evidentiary standards were both actively co-developed or available. As a result, we understand not only what Medical Affairs needs to deliver but why those requirements exist and how they will be interpreted over time.
As a result, we bring deep, repeatable understanding of:
-
What actually determines launch success in Medical Affairs at Global, Regional and Country level.
-
How to design Medical Affairs capabilities and functions for impact whilst optimising scientific integrity and visibility.
-
Where early decisions materially affect market access, scientific positioning, and long-term value.
-
How to align integrated evidence, governance, and field execution at scale.
-
Knowing what to prioritise at each stage of development, and how to be flexible to meet client requirements, in a way that de-risks development and launch readiness, for both market and client needs.
This is not a single case study.
It is pattern recognition built across multiple high profile global launches, where we sat at both internally and from a consulting perspective.
​
​
Senior leadership, not traditional consulting
Lumares works directly with board-level founders, CMOs, and executive teams to translate corporate strategy into Medical Affairs design and execution.
Having built and scaled Medical Affairs capabilities and departments in-house across multiple programmes and companies, where we sat at the senior leadership table in fast-growth biotechs and biopharma, we understand what it takes to:
-
Build successful functions from the ground up
-
Scale capability rapidly and credibly to drive impact
-
Embed senior decision-making early
-
Deliver impact in complex, high-pressure environments
We do not operate as a traditional consultancy. Our value lies not only in execution, but in recognising early which strategic decisions will determine success and which will quietly undermine it later.
Our Ethos
We believe the success of medical innovation depends on the quality of decisions made early, understanding of external stakeholder needs, and sustained throughout the lifecycle.
Too often, medical strategy, evidence generation, regulatory expectations, market access value, and organisational execution are developed in parallel rather than as a single integrated system. When products reach market, the consequences are clear.
Lumares exists to change that.
We believe impact is created when scientific insight is translated into decisions that hold up across development, launch, and real-world use, ultimately addressing genuine unmet medical needs.